Showing results (121-130 of 131) with videos related to
Sort By:
Pageof 14
Hematological Oncology|April 10, 2025
Daratumumab, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide, and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Meta-AnalysisLucio N Gordan, Rohan Medhekar, Alex Z Fu, et al.Drug and Alcohol Dependence|January 9, 2023
Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in IranMehrdad Khezri, Ali Mirzazadeh, Mostafa Shokoohi, et al.Antiviral Therapy|June 8, 2023
Feminizing hormone therapy in a Canadian cohort of transgender women with and without HIVIan Armstrong, Ashley Lacombe-Duncan, Mostafa Shokoohi, et al.The Canadian Journal of Hospital Pharmacy|October 17, 2022
Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort StudyAlison R McClean, Jason Trigg, Claudette Cardinal, et al.HIV Medicine|February 22, 2022
Short report: Characterizing HIV care among a clinical sample of transgender women living with HIVAshley Lacombe-Duncan, Mostafa Shokoohi, Yasmeen Persad, et al.British Journal of Anaesthesia|July 11, 2022
Comparative benefits and harms of individual opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised trialsAtefeh Noori, Behnam Sadeghirad, Li Wang, et al.JMIR Research Protocols|January 20, 2021
Clinical and Epidemiological Characteristics of Postdischarge Patients With COVID-19 in Tehran, Iran: Protocol for a Prospective Cohort Study (Tele-COVID-19 Study)Laya Jalilian Khave, Mohammad Vahidi, Dorsa Shirini, et al.The International Journal on Drug Policy|January 25, 2022
An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam studyAli Mirzazadeh, Samira Hosseini-Hooshyar, Armita Shahesmaeili, et al.Blood Cancer Journal|April 1, 2026
Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United StatesShaji Kumar, Katja C Weisel, Paul Spin, et al.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
A two-day workshop reviewing Canadian provincial and national HIV care cascade indicators, reporting, challenges, and recommendationsIoana A Nicolau, Mostafa Shokoohi, Joanne E McBane, et al.Pageof 14